GlassScriptPhysician profile
Emily M Edwards
NPI 1497067045
$4,817.92
in general payments reported to CMS, 2019-2025
39 companies · $862 in 2025
The $862 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $719 · 2020: $193 · 2021: $486 · 2022: $696 · 2023: $915 · 2024: $948 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,723.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $807.81 | 2019-2025 | |
| Abbvie INC. | $760.86 | 2021-2024 | Vraylar, Ubrelvy, Qulipta |
| Glaxosmithkline, LLC. | $709.44 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $426.29 | 2019-2025 | Wegovy, Ozempic, Saxenda |
| Lilly USA, LLC | $262.92 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $201.11 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Janssen Pharmaceuticals, INC | $179.75 | 2019-2021 | |
| Amgen INC. | $157.31 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.09 | 2019-2021 | |
| Daiichi Sankyo INC. | $110.18 | 2019-2024 | Injectafer |
| Abiomed | $109.52 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $103.99 | 2020-2023 | Eliquis, Camzyos |
| Abbott Laboratories | $93.94 | 2022-2025 | Freestyle Libre 3, Eterna |
| Boston Scientific Corporation | $85.53 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Amarin Pharma, INC. | $59.57 | 2020-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.